GRECX | VGSIX | GRECX / VGSIX | |
Total Expense Ratio | 1.96 | 0.27 | 726% |
Annual Report Gross Expense Ratio | 2.32 | 0.27 | 859% |
Fund Existence | 27 years | 29 years | - |
Gain YTD | 2.250 | 4.920 | 46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 81.5M | 63.8B | 0% |
Annual Yield % from dividends | 1.56 | 3.75 | 42% |
Returns for 1 year | 1.30 | 8.10 | 16% |
Returns for 3 years | -2.13 | 9.41 | -23% |
Returns for 5 years | 7.72 | 41.03 | 19% |
Returns for 10 years | -38.23 | 63.27 | -60% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
APCB | 29.40 | 0.02 | +0.07% |
ActivePassive Core Bond ETF | |||
XTR | 29.03 | N/A | N/A |
Global X S&P 500® Tail Risk ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology | |||
FICS | 39.48 | -0.15 | -0.38% |
First Trust Intl Developed Cap Strth ETF | |||
IJR | 112.91 | -1.24 | -1.09% |
iShares Core S&P Small-Cap ETF |